May 14, 2019 / 03:00PM GMT
Juan Esteban Avendano - BofA Merrill Lynch, Research Division - Associate
(technical difficulty)
Bank of America Healthcare Conference. I'm Juan Avendano, I'm one of analysts in the life sciences tools team run by Derik De Bruin. I focus on CROs and CDMOs. And here to kick it off, we have Catalent; their CFO, Wett Joseph; and Tom Castellano from IR. With that said, welcome, gentlemen. Pleasure to have you here once again. Wetteny, if you could please start up by just giving us some general comments on Catalent, the evolution of the company and where you see it now.
Wetteny N. Joseph - Catalent, Inc. - Senior VP & CFO
Sure. Thank you, Juan. And thanks for having us. Catalent is the world leader in advanced delivery dosage technologies and development solutions. We serve approximately 1,000 customers, supplying product into over 80 countries and really supply more than 70 billion doses a year. This is approximately 1 in every 20 doses taken across prescription and consumer. We're organized around 4 business segments. We have a Softgel business that we
Catalent Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers